Olaratumab
From Self-sufficiency
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Template:Infobox drug/mab source |
Target | PDGF-R α |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 1024603-93-7 |
ATC code | none |
Chemical data | |
Formula | C6554H10076N1736O2048S40 |
Molar mass | 147.2 kDa[[Script error: No such module "String".]] |
Olaratumab is a monoclonal antibody which is being developed by Imclone for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha.[1]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
40x30px | This monoclonal antibody-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Drugs that are a monoclonal antibody
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- 2Fix
- Pages with broken file links
- Monoclonal antibody stubs